Self-injection Devices Market Size, Share & Trends Analysis Report By Product (Autoinjectors, Needle-free Injectors), By Usability (Disposable, Reusable), By Application (Cancer, Pain Management), By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 72 Business Hours
Self-injection Devices Market Growth & Trends
The global self-injection devices market size is expected to reach USD 10.8 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 5.7% from 2022 to 2030. Increasing patient volume and rising prevalence of chronic diseases along with the high adoption of advanced drug delivery systems are factors estimated to surge the demand for self-injection devices.
Prevention of needlestick injury is a primary factor for healthcare professionals and companies to introduce self-injection devices such as autoinjectors. To avoid needlestick injuries to healthcare workers, the U.S., Europe, and other markets mandate the use of safety devices. Several auto-injectors provide the additional benefit of needlestick protection to healthcare professionals. It is expected that in the U.S. about 69,000 injuries can be prevented annually. Numerous auto-injectors have integral and passive safety features that eliminate or reduce the risk of injury.
Innovation in the field of New Drug Delivery Systems (NDDDS) has led to the rising demand for self-administered medications. The invention of novel injectable delivery devices such as pre-filled syringes, pen injectors, autoinjectors, and needle-free injectors has made the self-administration of drugs easier and more convenient for patients. The majority of biological drugs are delivered using injections, which include the threat of needlestick injuries. To minimize this issue, pharmaceutical firms are developing self-administered needle-free injectors and patient-friendly medication-device combination products.
The COVID-19 pandemic has altered expectations and perceptions of delivery settings and contributed to a rise in preference for self-administration medication. As this becomes the norm, several manufacturers are inclined to make the patient experience the vital component of drug delivery design. Significantly, the COVID-19 vaccines will increase the demand for injectable devices and the pandemic has also shown the benefit of self-use devices as well as connected devices. Post-pandemic there may be a rise in upcoming innovation in devices and pharma manufacturers will progressively collaborate to use self-injection devices in combination with other digital assets such as apps, phones, and personal computers. Eventually, this will bring the patient into far greater control of their care.
Self-injection Devices Market Report Highlights
Self-injection Devices Market Growth & Trends
The global self-injection devices market size is expected to reach USD 10.8 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 5.7% from 2022 to 2030. Increasing patient volume and rising prevalence of chronic diseases along with the high adoption of advanced drug delivery systems are factors estimated to surge the demand for self-injection devices.
Prevention of needlestick injury is a primary factor for healthcare professionals and companies to introduce self-injection devices such as autoinjectors. To avoid needlestick injuries to healthcare workers, the U.S., Europe, and other markets mandate the use of safety devices. Several auto-injectors provide the additional benefit of needlestick protection to healthcare professionals. It is expected that in the U.S. about 69,000 injuries can be prevented annually. Numerous auto-injectors have integral and passive safety features that eliminate or reduce the risk of injury.
Innovation in the field of New Drug Delivery Systems (NDDDS) has led to the rising demand for self-administered medications. The invention of novel injectable delivery devices such as pre-filled syringes, pen injectors, autoinjectors, and needle-free injectors has made the self-administration of drugs easier and more convenient for patients. The majority of biological drugs are delivered using injections, which include the threat of needlestick injuries. To minimize this issue, pharmaceutical firms are developing self-administered needle-free injectors and patient-friendly medication-device combination products.
The COVID-19 pandemic has altered expectations and perceptions of delivery settings and contributed to a rise in preference for self-administration medication. As this becomes the norm, several manufacturers are inclined to make the patient experience the vital component of drug delivery design. Significantly, the COVID-19 vaccines will increase the demand for injectable devices and the pandemic has also shown the benefit of self-use devices as well as connected devices. Post-pandemic there may be a rise in upcoming innovation in devices and pharma manufacturers will progressively collaborate to use self-injection devices in combination with other digital assets such as apps, phones, and personal computers. Eventually, this will bring the patient into far greater control of their care.
Self-injection Devices Market Report Highlights
- Needle-free injectors segment held the largest market share in 2021 owing to the rising demand for needle-free injectors and increased health consciousness among individuals
- The disposable segment held a significant market share in 2021 due to the ease of use and the presence of a built-in glass syringe that reduces the necessity of manually loading the glass syringe, eventually making it more convenient for patients
- The cancer segment is anticipated to gain the highest market share during the forecast period due to the increasing prevalence of cancer all across the globe
- North America led the market in 2021 owing to the increasing demand for self-injection devices used for the treatment of several chronic diseases
- The Asia Pacific region is expected to expand at the fastest CAGR during the forecast period due to the rising incidence of autoimmune diseases and high prevalence of cancer across several countries in the region
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Usability
1.1.3. Application
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective
1.9.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Usability outlook
2.2.3. Application outlook
2.2.4. Regional outlook
2.3. Competitive Insights
CHAPTER 3. SELF-INJECTION DEVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of chronic disorders
3.4.1.2. Technological advancements
3.4.1.3. Increasing cases of
3.4.2. Market restraint analysis
3.4.2.1. Lack of awareness in developing and underdeveloped economies
3.4.2.2. Stringent regulations
3.5. Self-injection Devices Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier product
3.5.1.2. Buyer product
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
CHAPTER 4. SELF-INJECTION DEVICES: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Definitions and Scope
4.1.1. Autoinjectors
4.1.2. Pen Injectors
4.1.3. Wearable Injectors
4.1.4. Needle-free Injectors
4.2. Product Market Share, 2021 & 2030
4.3. Segment Dashboard
4.4. Global Self-injection Devices Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
4.5.1. Autoinjectors
4.5.1.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.2. Pen Injectors
4.5.2.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.3. Wearable Injectors
4.5.3.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.4. Needle-free injectors
4.5.4.1. Market estimates and forecast 2017 to 2030 (USD Million)
CHAPTER 5. SELF-INJECTION DEVICES: USABILITY ESTIMATES & TREND ANALYSIS
5.1. Definitions and Scope
5.1.1. Disposable
5.1.2. Reusable
5.2. Usability Market Share, 2021 & 2030
5.3. Segment Dashboard
5.4. Global Self-Injection Devices Market by Usability Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
5.5.1. Disposable
5.5.1.1. Market estimates and forecast 2017 to 2030 (USD million)
5.5.2. Reusable
5.5.2.1. Market estimates and forecast 2017 to 2030 (USD Million)
CHAPTER 6. SELF-INJECTION DEVICES: APPLICATION ESTIMATES & TREND ANALYSIS
6.1. Definitions and Scope
6.1.1. Cancer
6.1.2. Autoimmune Disorders
6.1.3. Hormonal Disorders
6.1.4. Pain Management
6.1.5. Others
6.2. Application Market Share, 2021 & 2030
6.3. Segment Dashboard
6.4. Global Self-injection Devices Market by Application Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
6.5.1. Cancer
6.5.1.1. Market estimates and forecast 2017 to 2030 (USD million)
6.5.2. Autoimmune Disorders
6.5.2.1. Market estimates and forecast 2017 to 2030 (USD Million)
6.5.3. Hormonal Disorders
6.5.3.1. Market estimates and forecast 2017 to 2030 (USD Million)
6.5.4. Pain Management
6.5.4.1. Market estimates and forecast 2017 to 2030 (USD Million)
6.5.5. Others
6.5.5.1. Market estimates and forecast 2017 to 2030 (USD Million)
CHAPTER 7. SELF-INJECTION DEVICES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional market share analysis, 2021 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2020
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2017 to 2030:
7.7. North America
7.7.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.7.2. U.S.
7.7.2.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.7.3. Canada
7.7.3.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.8. Europe
7.8.1. U.K.
7.8.1.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.8.2. Germany
7.8.2.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.8.3. France
7.8.3.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.8.4. Italy
7.8.4.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.8.5. Spain
7.8.5.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.9. Asia Pacific
7.9.1. China
7.9.1.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.9.2. Japan
7.9.2.1. Market estimates and forecast, 2017 - 2030 (Volume, Thousand)
7.9.3. India
7.9.3.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.9.4. South Korea
7.9.4.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.9.5. Australia
7.9.5.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.10. Latin America
7.10.1. Brazil
7.10.1.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.10.2. Mexico
7.10.2.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.10.3. Argentina
7.10.3.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.10.4. Colombia
7.10.4.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.11. MEA
7.11.1. Saudi Arabia
7.11.1.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.11.2. South Africa
7.11.2.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.11.3. UAE
7.11.3.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2021
8.3.4. Ypsomed AG.
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. BD
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Gerresheimer AG
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Antares Pharma
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Haselmeier AG
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. NuGen Medical Devices
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Owen Mumford Ltd.
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. SHL Medical AG
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Pfizer, Inc.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Amgen
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Usability
1.1.3. Application
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective
1.9.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Usability outlook
2.2.3. Application outlook
2.2.4. Regional outlook
2.3. Competitive Insights
CHAPTER 3. SELF-INJECTION DEVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of chronic disorders
3.4.1.2. Technological advancements
3.4.1.3. Increasing cases of
3.4.2. Market restraint analysis
3.4.2.1. Lack of awareness in developing and underdeveloped economies
3.4.2.2. Stringent regulations
3.5. Self-injection Devices Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier product
3.5.1.2. Buyer product
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
CHAPTER 4. SELF-INJECTION DEVICES: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Definitions and Scope
4.1.1. Autoinjectors
4.1.2. Pen Injectors
4.1.3. Wearable Injectors
4.1.4. Needle-free Injectors
4.2. Product Market Share, 2021 & 2030
4.3. Segment Dashboard
4.4. Global Self-injection Devices Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
4.5.1. Autoinjectors
4.5.1.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.2. Pen Injectors
4.5.2.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.3. Wearable Injectors
4.5.3.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.4. Needle-free injectors
4.5.4.1. Market estimates and forecast 2017 to 2030 (USD Million)
CHAPTER 5. SELF-INJECTION DEVICES: USABILITY ESTIMATES & TREND ANALYSIS
5.1. Definitions and Scope
5.1.1. Disposable
5.1.2. Reusable
5.2. Usability Market Share, 2021 & 2030
5.3. Segment Dashboard
5.4. Global Self-Injection Devices Market by Usability Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
5.5.1. Disposable
5.5.1.1. Market estimates and forecast 2017 to 2030 (USD million)
5.5.2. Reusable
5.5.2.1. Market estimates and forecast 2017 to 2030 (USD Million)
CHAPTER 6. SELF-INJECTION DEVICES: APPLICATION ESTIMATES & TREND ANALYSIS
6.1. Definitions and Scope
6.1.1. Cancer
6.1.2. Autoimmune Disorders
6.1.3. Hormonal Disorders
6.1.4. Pain Management
6.1.5. Others
6.2. Application Market Share, 2021 & 2030
6.3. Segment Dashboard
6.4. Global Self-injection Devices Market by Application Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
6.5.1. Cancer
6.5.1.1. Market estimates and forecast 2017 to 2030 (USD million)
6.5.2. Autoimmune Disorders
6.5.2.1. Market estimates and forecast 2017 to 2030 (USD Million)
6.5.3. Hormonal Disorders
6.5.3.1. Market estimates and forecast 2017 to 2030 (USD Million)
6.5.4. Pain Management
6.5.4.1. Market estimates and forecast 2017 to 2030 (USD Million)
6.5.5. Others
6.5.5.1. Market estimates and forecast 2017 to 2030 (USD Million)
CHAPTER 7. SELF-INJECTION DEVICES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional market share analysis, 2021 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2020
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2017 to 2030:
7.7. North America
7.7.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.7.2. U.S.
7.7.2.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.7.3. Canada
7.7.3.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.8. Europe
7.8.1. U.K.
7.8.1.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.8.2. Germany
7.8.2.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.8.3. France
7.8.3.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.8.4. Italy
7.8.4.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.8.5. Spain
7.8.5.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.9. Asia Pacific
7.9.1. China
7.9.1.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.9.2. Japan
7.9.2.1. Market estimates and forecast, 2017 - 2030 (Volume, Thousand)
7.9.3. India
7.9.3.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.9.4. South Korea
7.9.4.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.9.5. Australia
7.9.5.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.10. Latin America
7.10.1. Brazil
7.10.1.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.10.2. Mexico
7.10.2.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.10.3. Argentina
7.10.3.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.10.4. Colombia
7.10.4.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.11. MEA
7.11.1. Saudi Arabia
7.11.1.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.11.2. South Africa
7.11.2.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
7.11.3. UAE
7.11.3.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2021
8.3.4. Ypsomed AG.
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. BD
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Gerresheimer AG
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Antares Pharma
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Haselmeier AG
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. NuGen Medical Devices
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Owen Mumford Ltd.
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. SHL Medical AG
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Pfizer, Inc.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Amgen
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
LIST OF TABLES
Table 1 List of Abbreviation
Table 2 North America self-injection devices market, by region, 2017 - 2030 (USD Million)
Table 3 North America self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 4 North America self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 5 North America self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 6 U.S. self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 7 U.S. self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 8 U.S. self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 9 Canada self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 10 Canada self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 11 Canada self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 12 Europe self-injection devices market, by region, 2017 - 2030 (USD Million)
Table 13 Europe self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 14 Europe self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 15 Europe self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 16 Germany self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 17 Germany self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 18 Germany self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 19 U.K. self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 20 U.K. self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 21 U.K. self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 22 France self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 23 France self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 24 France self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 25 Italy self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 26 Italy self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 27 Italy self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 28 Spain self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 29 Spain self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 30 Spain self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 31 Asia Pacific self-injection devices market, by region, 2017 - 2030 (USD Million)
Table 32 Asia Pacific self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 33 Asia Pacific self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 34 Asia Pacific self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 35 China self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 36 China self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 37 China self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 38 Japan self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 39 Japan self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 40 Japan self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 41 India self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 42 India self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 43 India self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 44 South Korea self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 45 South Korea self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 46 South Korea self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 47 Australia self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 48 Australia self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 49 Australia self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 50 Latin America self-injection devices market, by region, 2017 - 2030 (USD Million)
Table 51 Latin America self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 52 Latin America self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 53 Latin America self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 54 Brazil self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 55 Brazil self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 56 Brazil self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 57 Mexico self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 58 Mexico self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 59 Mexico self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 60 Argentina self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 61 Argentina self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 62 Argentina self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 63 Colombia self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 64 Colombia self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 65 Colombia self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 66 Middle East and Africa self-injection devices market, by region, 2017 - 2030 (USD Million)
Table 67 Middle East and Africa self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 68 Middle East and Africa self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 69 Middle East and Africa self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 70 South Africa self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 71 South Africa self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 72 South Africa self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 73 Saudi Arabia self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 74 Saudi Arabia self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 75 Saudi Arabia self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 76 UAE self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 77 UAE self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 78 UAE self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 1 List of Abbreviation
Table 2 North America self-injection devices market, by region, 2017 - 2030 (USD Million)
Table 3 North America self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 4 North America self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 5 North America self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 6 U.S. self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 7 U.S. self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 8 U.S. self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 9 Canada self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 10 Canada self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 11 Canada self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 12 Europe self-injection devices market, by region, 2017 - 2030 (USD Million)
Table 13 Europe self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 14 Europe self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 15 Europe self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 16 Germany self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 17 Germany self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 18 Germany self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 19 U.K. self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 20 U.K. self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 21 U.K. self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 22 France self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 23 France self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 24 France self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 25 Italy self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 26 Italy self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 27 Italy self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 28 Spain self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 29 Spain self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 30 Spain self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 31 Asia Pacific self-injection devices market, by region, 2017 - 2030 (USD Million)
Table 32 Asia Pacific self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 33 Asia Pacific self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 34 Asia Pacific self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 35 China self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 36 China self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 37 China self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 38 Japan self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 39 Japan self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 40 Japan self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 41 India self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 42 India self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 43 India self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 44 South Korea self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 45 South Korea self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 46 South Korea self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 47 Australia self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 48 Australia self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 49 Australia self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 50 Latin America self-injection devices market, by region, 2017 - 2030 (USD Million)
Table 51 Latin America self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 52 Latin America self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 53 Latin America self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 54 Brazil self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 55 Brazil self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 56 Brazil self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 57 Mexico self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 58 Mexico self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 59 Mexico self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 60 Argentina self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 61 Argentina self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 62 Argentina self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 63 Colombia self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 64 Colombia self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 65 Colombia self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 66 Middle East and Africa self-injection devices market, by region, 2017 - 2030 (USD Million)
Table 67 Middle East and Africa self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 68 Middle East and Africa self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 69 Middle East and Africa self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 70 South Africa self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 71 South Africa self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 72 South Africa self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 73 Saudi Arabia self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 74 Saudi Arabia self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 75 Saudi Arabia self-injection devices market, by application, 2017 - 2030 (USD Million)
Table 76 UAE self-injection devices market, by product, 2017 - 2030 (USD Million)
Table 77 UAE self-injection devices market, by usability, 2017 - 2030 (USD Million)
Table 78 UAE self-injection devices market, by application, 2017 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Self-injection devices Market: Market Outlook
Fig. 14 Self-injection devices Competitive Insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Self-injection devices market driver impact
Fig. 20 Self-injection devices market restraint impact
Fig. 21 Self-injection devices market strategic initiatives analysis
Fig. 22 Self-injection devices market: Product movement analysis
Fig. 23 Self-injection devices market: product outlook and key takeaways
Fig. 24 Autoinjectors market estimates and forecast, 2017 - 2030
Fig. 25 Pen injectors market estimates and forecast, 2017 - 2030
Fig. 26 Wearable injectors market estimates and forecast, 2017 - 2030
Fig. 27 Needle-free injectors market estimates and forecast, 2017 - 2030
Fig. 28 Self-injection devices market: Usability movement analysis
Fig. 29 Self-injection devices market: Usability outlook and key takeaways
Fig. 30 Disposable market estimates and forecast, 2017 - 2030
Fig. 31 Reusable market estimates and forecast,2017 - 2030
Fig. 32 Self-injection devices market: Application movement analysis
Fig. 33 Self-injection devices market: Application outlook and key takeaways
Fig. 34 Cancer market estimates and forecast, 2017 - 2030
Fig. 35 Autoimmune disorders market estimates and forecast,2017 - 2030
Fig. 36 Hormonal disorders estimates and forecast, 2017 - 2030
Fig. 37 Pain management estimates and forecast, 2017 - 2030
Fig. 38 Others estimates and forecasts, 2017 - 2030
Fig. 39 Global self-injection devices market: Regional movement analysis
Fig. 40 Global self-injection devices market: Regional outlook and key takeaways
Fig. 41 Global self-injection devices market share and leading players
Fig. 42 North America market share and leading players
Fig. 43 Europe market share and leading players
Fig. 44 Asia Pacific market share and leading players
Fig. 45 Latin America market share and leading players
Fig. 46 Middle East & Africa market share and leading players
Fig. 47 North America: SWOT
Fig. 48 Europe SWOT
Fig. 49 Asia Pacific SWOT
Fig. 50 Latin America SWOT
Fig. 51 MEA SWOT
Fig. 52 North America, by country
Fig. 53 North America
Fig. 54 North America market estimates and forecast, 2017 - 2030
Fig. 55 U.S.
Fig. 56 U.S. market estimates and forecast, 2017 - 2030
Fig. 57 Canada
Fig. 58 Canada market estimates and forecast, 2017 - 2030
Fig. 59 Europe
Fig. 60 Europe market estimates and forecast, 2017 - 2030
Fig. 61 U.K.
Fig. 62 U.K. market estimates and forecast, 2017 - 2030
Fig. 63 Germany
Fig. 64 Germany market estimates and forecast, 2017 - 2030
Fig. 65 France
Fig. 66 France market estimates and forecast, 2017 - 2030
Fig. 67 Italy
Fig. 68 Italy market estimates and forecast, 2017 - 2030
Fig. 69 Spain
Fig. 70 Spain market estimates and forecast, 2017 - 2030
Fig. 71 Asia Pacific
Fig. 72 Asia Pacific market estimates and forecast, 2017 - 2030
Fig. 73 China
Fig. 74 China market estimates and forecast, 2017 - 2030
Fig. 75 Japan
Fig. 76 Japan market estimates and forecast, 2017 - 2030
Fig. 77 India
Fig. 78 India market estimates and forecast, 2017 - 2030
Fig. 79 South Korea
Fig. 80 South Korea market estimates and forecast, 2017 - 2030
Fig. 81 Australia
Fig. 82 Australia market estimates and forecast, 2017 - 2030
Fig. 83 Latin America
Fig. 84 Latin America market estimates and forecast, 2017 - 2030
Fig. 85 Brazil
Fig. 86 Brazil market estimates and forecast, 2017 - 2030
Fig. 87 Mexico
Fig. 88 Mexico market estimates and forecast, 2017 - 2030
Fig. 89 Argentina
Fig. 90 Argentina market estimates and forecast, 2017 - 2030
Fig. 91 Colombia
Fig. 92 Colombia market estimates and forecast, 2017 - 2030
Fig. 93 Middle East and Africa
Fig. 94 Middle East and Africa market estimates and forecast, 2017 - 2030
Fig. 95 South Africa
Fig. 96 South Africa market estimates and forecast, 2017 - 2030
Fig. 97 Saudi Arabia
Fig. 98 Saudi Arabia market estimates and forecast, 2017 - 2030
Fig. 99 UAE
Fig. 100 UAE market estimates and forecast, 2017 - 2030
Fig. 101 Participant Categorization- Self-injection devices market
Fig. 102 Market share of key market players- Self-injection devices market
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Self-injection devices Market: Market Outlook
Fig. 14 Self-injection devices Competitive Insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Self-injection devices market driver impact
Fig. 20 Self-injection devices market restraint impact
Fig. 21 Self-injection devices market strategic initiatives analysis
Fig. 22 Self-injection devices market: Product movement analysis
Fig. 23 Self-injection devices market: product outlook and key takeaways
Fig. 24 Autoinjectors market estimates and forecast, 2017 - 2030
Fig. 25 Pen injectors market estimates and forecast, 2017 - 2030
Fig. 26 Wearable injectors market estimates and forecast, 2017 - 2030
Fig. 27 Needle-free injectors market estimates and forecast, 2017 - 2030
Fig. 28 Self-injection devices market: Usability movement analysis
Fig. 29 Self-injection devices market: Usability outlook and key takeaways
Fig. 30 Disposable market estimates and forecast, 2017 - 2030
Fig. 31 Reusable market estimates and forecast,2017 - 2030
Fig. 32 Self-injection devices market: Application movement analysis
Fig. 33 Self-injection devices market: Application outlook and key takeaways
Fig. 34 Cancer market estimates and forecast, 2017 - 2030
Fig. 35 Autoimmune disorders market estimates and forecast,2017 - 2030
Fig. 36 Hormonal disorders estimates and forecast, 2017 - 2030
Fig. 37 Pain management estimates and forecast, 2017 - 2030
Fig. 38 Others estimates and forecasts, 2017 - 2030
Fig. 39 Global self-injection devices market: Regional movement analysis
Fig. 40 Global self-injection devices market: Regional outlook and key takeaways
Fig. 41 Global self-injection devices market share and leading players
Fig. 42 North America market share and leading players
Fig. 43 Europe market share and leading players
Fig. 44 Asia Pacific market share and leading players
Fig. 45 Latin America market share and leading players
Fig. 46 Middle East & Africa market share and leading players
Fig. 47 North America: SWOT
Fig. 48 Europe SWOT
Fig. 49 Asia Pacific SWOT
Fig. 50 Latin America SWOT
Fig. 51 MEA SWOT
Fig. 52 North America, by country
Fig. 53 North America
Fig. 54 North America market estimates and forecast, 2017 - 2030
Fig. 55 U.S.
Fig. 56 U.S. market estimates and forecast, 2017 - 2030
Fig. 57 Canada
Fig. 58 Canada market estimates and forecast, 2017 - 2030
Fig. 59 Europe
Fig. 60 Europe market estimates and forecast, 2017 - 2030
Fig. 61 U.K.
Fig. 62 U.K. market estimates and forecast, 2017 - 2030
Fig. 63 Germany
Fig. 64 Germany market estimates and forecast, 2017 - 2030
Fig. 65 France
Fig. 66 France market estimates and forecast, 2017 - 2030
Fig. 67 Italy
Fig. 68 Italy market estimates and forecast, 2017 - 2030
Fig. 69 Spain
Fig. 70 Spain market estimates and forecast, 2017 - 2030
Fig. 71 Asia Pacific
Fig. 72 Asia Pacific market estimates and forecast, 2017 - 2030
Fig. 73 China
Fig. 74 China market estimates and forecast, 2017 - 2030
Fig. 75 Japan
Fig. 76 Japan market estimates and forecast, 2017 - 2030
Fig. 77 India
Fig. 78 India market estimates and forecast, 2017 - 2030
Fig. 79 South Korea
Fig. 80 South Korea market estimates and forecast, 2017 - 2030
Fig. 81 Australia
Fig. 82 Australia market estimates and forecast, 2017 - 2030
Fig. 83 Latin America
Fig. 84 Latin America market estimates and forecast, 2017 - 2030
Fig. 85 Brazil
Fig. 86 Brazil market estimates and forecast, 2017 - 2030
Fig. 87 Mexico
Fig. 88 Mexico market estimates and forecast, 2017 - 2030
Fig. 89 Argentina
Fig. 90 Argentina market estimates and forecast, 2017 - 2030
Fig. 91 Colombia
Fig. 92 Colombia market estimates and forecast, 2017 - 2030
Fig. 93 Middle East and Africa
Fig. 94 Middle East and Africa market estimates and forecast, 2017 - 2030
Fig. 95 South Africa
Fig. 96 South Africa market estimates and forecast, 2017 - 2030
Fig. 97 Saudi Arabia
Fig. 98 Saudi Arabia market estimates and forecast, 2017 - 2030
Fig. 99 UAE
Fig. 100 UAE market estimates and forecast, 2017 - 2030
Fig. 101 Participant Categorization- Self-injection devices market
Fig. 102 Market share of key market players- Self-injection devices market
